logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-108. New clients entering inpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (vi) New volatile inhalant inpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium00000000000
Bulgaria00010000101
Czech Republic01000000101
Denmark00000000000
Germany00000100101
Estonia:::::::::::
Ireland100000000000
Greece00000000000
Spain:::::::::::
France:::::::::::
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary21000000303
Malta:::::::::::
Netherlands00000000011
Austria00000000000
Poland2:::1:::::::
Portugal:::::::::::
Romania24000000628
Slovenia:::::::::::
Slovakia101100000021021
Finland00000000000
Sweden100000010101
United Kingdom3:::::::::::
Croatia:::::::::::
Turkey363840001079584
Norway:::::::::::
Total50554201201138121
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

The number of treatment clients in each country is listed in [Table TDI-7]

See also Table TDI-11 part(v), part(vi)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013